These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3104392)

  • 1. Peripheral blood mononuclear-cell interleukin-2 production, receptor generation and lymphokine-activated cytotoxicity in inflammatory bowel disease.
    Ming RH; Atluru D; Spellman CW; Imir T; Goodwin JS; Strickland RG
    J Clin Immunol; 1987 Jan; 7(1):59-63. PubMed ID: 3104392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal immune reactivity to interleukin 2 differs among Crohn's disease, ulcerative colitis, and controls.
    Kusugami K; Youngman KR; West GA; Fiocchi C
    Gastroenterology; 1989 Jul; 97(1):1-9. PubMed ID: 2785943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell activation in Crohn's disease. Increased levels of soluble interleukin-2 receptor in serum and in supernatants of stimulated peripheral blood mononuclear cells.
    Mueller C; Knoflach P; Zielinski CC
    Gastroenterology; 1990 Mar; 98(3):639-46. PubMed ID: 2298368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of interleukin-2-producing intestinal CD4+ T cells in inflammatory bowel disease.
    Kusugami K; Matsuura T; West GA; Youngman KR; Rachmilewitz D; Fiocchi C
    Gastroenterology; 1991 Dec; 101(6):1594-605. PubMed ID: 1683326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 2 activity of human intestinal mucosa mononuclear cells. Decreased levels in inflammatory bowel disease.
    Fiocchi C; Hilfiker ML; Youngman KR; Doerder NC; Finke JH
    Gastroenterology; 1984 Apr; 86(4):734-42. PubMed ID: 6607860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysis of colonic epithelial cells by allogeneic mononuclear and lymphokine activated killer cells derived from peripheral blood and intestinal mucosa: evidence against a pathogenic role in inflammatory bowel disease.
    Gibson PR; van de Pol E; Pullman W; Doe WF
    Gut; 1988 Aug; 29(8):1076-84. PubMed ID: 3261705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-2 production in pediatric inflammatory bowel disease: evidence for dissimilar mononuclear cell function in Crohn's disease and ulcerative colitis.
    Gurbindo C; Sabbah S; Menezes J; Justinich C; Marchand R; Seidman EG
    J Pediatr Gastroenterol Nutr; 1993 Oct; 17(3):247-54. PubMed ID: 8271122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
    Fuss IJ; Neurath M; Boirivant M; Klein JS; de la Motte C; Strong SA; Fiocchi C; Strober W
    J Immunol; 1996 Aug; 157(3):1261-70. PubMed ID: 8757634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanded CD4+CD45RO+ phenotype and defective proliferative response in T lymphocytes from patients with Crohn's disease.
    Roman LI; Manzano L; De La Hera A; Abreu L; Rossi I; Alvarez-Mon M
    Gastroenterology; 1996 Apr; 110(4):1008-19. PubMed ID: 8612987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural, lectin- and phorbol ester-induced cellular cytotoxicity in Crohn's disease and ulcerative colitis.
    Aparicio-Pagés MN; Verspaget HW; Peña AS; Weterman IT; Mieremet-Ooms MA; van der Zon JM; de Bruin PA; Lamers CB
    J Clin Lab Immunol; 1988 Nov; 27(3):109-13. PubMed ID: 3246686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased activation of isolated intestinal lamina propria mononuclear cells in inflammatory bowel disease.
    Schreiber S; MacDermott RP; Raedler A; Pinnau R; Bertovich MJ; Nash GS
    Gastroenterology; 1991 Oct; 101(4):1020-30. PubMed ID: 1889695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens.
    Pallone F; Fais S; Squarcia O; Biancone L; Pozzilli P; Boirivant M
    Gut; 1987 Jun; 28(6):745-53. PubMed ID: 3040543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine production in patients with inflammatory bowel disease.
    Nakamura M; Saito H; Kasanuki J; Tamura Y; Yoshida S
    Gut; 1992 Jul; 33(7):933-7. PubMed ID: 1644332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant increase of interleukin 6 production in blood mononuclear leukocytes obtained from patients with active inflammatory bowel disease.
    Suzuki Y; Saito H; Kasanuki J; Kishimoto T; Tamura Y; Yoshida S
    Life Sci; 1990; 47(24):2193-7. PubMed ID: 2266787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitization to epithelial antigens in chronic mucosal inflammatory disease. III. Serum factor modulates circulating and mucosal mononuclear-cell reactivity to epithelial cell-associated components of colon (ECAC-C).
    Dunkel G; Paul JW; Roche JK
    J Clin Immunol; 1987 Mar; 7(2):159-73. PubMed ID: 3571435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell abnormalities in inflammatory bowel disease are mediated by interleukin 2.
    Ebert EC; Wright SH; Lipshutz WH; Hauptman SP
    Clin Immunol Immunopathol; 1984 Nov; 33(2):232-44. PubMed ID: 6237813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased in vitro release of soluble interleukin 2 receptor by colonic lamina propria mononuclear cells in inflammatory bowel disease.
    Schreiber S; Raedler A; Conn AR; Rombeau JL; MacDermott RP
    Gut; 1992 Feb; 33(2):236-41. PubMed ID: 1541420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 2 receptor expression by macrophages in inflammatory bowel disease.
    Mahida YR; Patel S; Wu K; Jewell DP
    Clin Exp Immunol; 1988 Dec; 74(3):382-6. PubMed ID: 3266118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral blood mononuclear cells from patients with inflammatory bowel disease exhibit normal function in the allogeneic and autologous mixed leukocyte reaction and cell-mediated lympholysis.
    MacDermott RP; Bragdon MJ; Thurmond RD
    Gastroenterology; 1984 Mar; 86(3):476-84. PubMed ID: 6229444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human intestinal mucosal mononuclear cells exhibit lymphokine-activated killer cell activity.
    Fiocchi C; Tubbs RR; Youngman KR
    Gastroenterology; 1985 Mar; 88(3):625-37. PubMed ID: 3917958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.